Evidence map›Paper›PMID 28943810›Full record

ArticlePoint of care2017

Type 1 Diabetes - A Clinical Perspective.

Lindy Kahanovitz, Patrick M Sluss, Steven J Russell

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Point of care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Pathogenesis and advances in immunotherapy for type 1 diabetes treatment.Biotechnology reports (Amsterdam, Netherlands) · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Protective factors in resilient South African youth with type 1 diabetes: A qualitative study.African journal of primary health care & family medicine · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Lindy KahanovitzDepartment of Biotechnology Engineering, Ben Gurion University of the Negev, Beersheva, Israel.
Patrick M SlussPathology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Steven J RussellDiabetes Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ben-Gurion University of the Negev · ILMassachusetts General Hospital · US

Funding

A multicenter outpatient trial of a bihormonal pancreasDP3DK101084 · NIDDK · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI DAMIANO, EDWARD, RUSSELL, STEVEN J · 2013 to 2015
$3.1M
NIDDK NIH HHS DP3 DK101084
6 · The paper itself

Abstract

Type 1 diabetes is a disease in which autoimmune destruction of pancreatic β-cells leads to insulin deficiency. Controlling blood glucose with an acceptable range is a major goal of therapy. Measurements of hemoglobin A1c and blood glucose levels are used for both the diagnosis and the long-term management of the disease. This chapter briefly describes the pathophysiology, diagnosis, and management of type 1 diabetes.

Indexed as

continuous glucose monitoringC-peptidehemoglobin A1cinsulinpoint of careself monitoring blood glucoseType 1 diabetes

Identifiers

PMID28943810
PMCPMC5606981
OpenAlexW2589143196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.